Company Badge
USPTO Data Jan 1 1976 - Oct 13 2026
5 Patents
#368 in Cambridge, MA
#2,894 in Massachusetts
#51,620 in US
Q-State Biosciences, Inc.
Forward Citations = 20
7 inventors:
Cambridge, MA, United States of America
Q-State Biosciences, Inc.
CIPO Patents = 3
EPO Patents = 1
Forward Citations = 20
Loading Chart...
Loading Chart...
7 inventors (with patents filed for the assignee):
Adam Ezra Cohen (5 out of 26 patents)
Joel Kralj (4 out of 11 patents)
Evangelos Kiskinis (3 out of 7 patents)
4. Kevin C Eggan (3 out of 10 patents)
5. Christopher Werley (2 out of 8 patents)
6. Steven Charles Wasserman (1 out of 6 patents)
7. Graham Dempsey (1 out of 1 patent)
8. Adam Cohen (0 patent)
5 patents:
Company Overview
Q-State Biosciences, Inc. is a biotechnology company focused on developing novel treatments for neurological disorders. With a mission to pioneer the next generation of precision medicines, Q-State leverages cutting-edge technologies to better understand the biology of the brain and develop innovative therapies. Through their innovative approach, Q-State aims to bring transformative therapies to patients in need.
Profile summary synthesized from public USPTO records and patent filings.
IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Q-State Biosciences, Inc.. Retrieved from https://idiyas.com/company/q-state-biosciences
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
3 patents (CIPO):
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
1 patent (EPO):
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]